The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Hydroxyzine hydrochloride 25 mg film-coated tablets



Brillpharma (Ireland) LimitedPA22749/025/001

Main Information

Trade NameHydroxyzine hydrochloride 25 mg film-coated tablets
Active SubstancesHydroxyzine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/025/001

Group Information

ATC CodeN05BB Diphenylmethane derivatives
N05BB01 hydroxyzine

Status

License statusAuthorised
Licence Issued02/12/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back